Anastrazole 1mg Hilma Biocare

£50.00

Anastrazole 1mg Hilma Biocare provides researchers with pharmaceutical-grade aromatase inhibitor for in-vitro studies investigating estrogen regulation pathways and hormonal interaction mechanisms.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Anastrazole 1mg Hilma Biocare
Anastrazole 1mg Hilma Biocare
£50.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: Anastrazole

Anastrazole is a selective aromatase inhibitor extensively studied for its mechanisms of estrogen regulation in laboratory research environments. This pharmaceutical compound from Hilma Biocare enables researchers at Stroid UK Shop to investigate hormonal pathway interactions and enzymatic inhibition processes. Each 1mg formulation delivers precise concentrations for controlled experimental protocols examining aromatase enzyme activity. Research teams utilise this compound to study estrogen synthesis pathways and evaluate cellular responses to hormonal modulation in controlled laboratory settings.

Laboratory Applications

Research scientists examine anastrazole’s effects on aromatase enzyme inhibition across various experimental models. Studies investigate the compound’s selectivity for aromatase versus other cytochrome P450 enzymes, providing insights into enzymatic specificity mechanisms. Researchers analyse cellular responses to estrogen depletion in hormone-dependent cell cultures and tissue samples. Comparative studies with other aromatase inhibitors reveal distinct pharmacological profiles and binding affinities. Laboratory protocols evaluate dose-response relationships in enzymatic inhibition assays and cellular viability assessments. Research applications extend to investigating metabolic pathways influenced by estrogen regulation and downstream signalling cascades. Scientists study the compound’s interaction with steroid biosynthesis pathways alongside selective androgen receptor modulators and research peptides in comprehensive hormonal research programmes.

Technical Specifications

Anastrazole 1mg Hilma Biocare Laboratory Specifications
Parameter Specification
Active Compound Anastrazole
Concentration 1mg per tablet
Manufacturer Hilma Biocare
Purity ≥98%
CAS Number 120511-73-1
Molecular Formula C17H19N5
Molecular Weight 293.37 g/mol
Storage Room temperature, dry conditions
Tablet Count 50 tablets per package

Research Compliance

This anastrazole formulation is manufactured exclusively for in-vitro research applications and laboratory studies. Researchers must maintain appropriate storage conditions and follow institutional guidelines for handling pharmaceutical research compounds. All experimental protocols should comply with laboratory safety standards and ethical research practices. This product is not intended for human consumption and must be used solely for scientific research purposes under qualified laboratory supervision.

Related